Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid

Abstract

Get full access to this article

View all access options for this article.

References

Heidelbaugh

Kim

Chang

Walker

PC.

Overutilization of proton-pump inhibitors: what the clinician needs to know. Ther Adv Gastroenterol 2012;5(4):219-32.

Freedberg

Kim

Yang

Y-X.

The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology 2017;152(4):706-15.

Thompson

Black

Welch

et al . Patient values and preferences surrounding proton pump inhibitor use: a scoping review. Patient 2018;11(1):17-28.

Reeve

Hendrix

et al . Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 2013;30(10):793-807.

Stacey

Légaré

Lyddiatt

et al . Translating evidence to facilitate shared decision making: development and usability of a consult decision aid prototype. Patient 2016;9(6):571-82.

Stacey

Légaré

Col

et al . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2014;(1):CD001431.

O’Connor

Jacobsen

Workbook on developing and evaluating patient decision aids. 2003; Available: https://decisionaid.ohri.ca/docs/develop/develop_da.pdf (accessed Oct. 14, 2016).

Thompson

Farrell

Welch

et al . Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid. Can Pharm J (Ott) 2017;150(1):19-21.

O’Connor

User Manual—Decisional Conflict Scale [Internet]. 2010. p. 1-16. Available: https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_decisional_conflict.pdf (accessed April 7, 2016).

10.

Sepucha

Borkhoff

Lally

et al . Establishing the effectiveness of patient decision aids: key constructs and measurement instruments. BMC Med Inform Decis Mak 2013;13(Suppl 2):S12.

11.

Shultz

Jimbo

Decision aid use in primary care: an overview and theory-based framework. Fam Med 2015;47(9):679-92.

12.

Reeve

Andrews

Wiese

et al . Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Ann Pharmacother 2015;49(1):29-38.

13.

Sirois

Ouellet

Reeve

Community-dwelling older people’s attitudes towards deprescribing in Canada. Res Soc Adm Pharm 2017;13(4):864-70.